Phase-III Study of AJM300 in Patients with Active Ulcerative Colitis
Phase of Trial: Phase III
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Carotegrast (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Ajinomoto Pharma; EA Pharma
- 22 Jun 2016 Status changed from active, no longer recruiting to recruiting.
- 20 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 09 Jun 2016 New trial record